Name Position
Mr. Juan López-Belmonte López President
Mr. Juan López-Belmonte Encina CEO
Mr. Iván López-Belmonte Encina Vicepresident 1
Mr. Javier López-Belmonte Encina Vicepresident 2
Mr. Enrique Castellón Leal Coordinating counselor
Mr. José Fernando de Almansa Moreno-Barreda Board member
Mr. Marcos Peña Pinto Board member
Mr. Gabriel Nuñez Fernández Secretary non board member
Mr. Ignacio Zarzalejos Toledano Deputy Secretary non board member

The Board of Directors s the Company’s highest decision-making, supervision and control body, except in matters reserved to the General Shareholders’ Meeting.

 

Its composition is adapted to the recommendations of the CNMV’s Good Governance Code for Companies.

 

All the directors were appointed on the basis of their merits, irrespective of gender.

 

According to the Bylaws, the Board must be formed by no less than five and no more than fifteen members.

 

As the highest decision-making body, it delegates ordinary business management to the management team and concentrates its activities on general supervisory duties.

 

Therefore, the Board must direct its policies towards:

  • Supervising Management
  • Evaluating the perfomance of managers
  • Adopting the Company's most important decisions
  • Liaising with shareholders

Duties:

  • To strive to ensure the regulatory requirements and the Company’s social and ethical duties are met
  • To ensure that no one person or small group exercises decision-making power within the Company
  • To ensure that no shareholder is treated more favourably than others

Responsibilities:

  • Preparing the strategic plan
  • Fixing management objectives and the annual budget
  • Defining the structure of the company group
  • Establishing the investment and financing policy
  • Approving the dividend, corporate governance and social responsibility policies

All the responsibilities of the Board of Directors are set out in article 5 of the Regulations of the Board of Directors.

 

Directors

Mr. Juan López-Belmonte López

Chairman and Chief Executive Manager

PositionDominical

First Appointment27 July, 2007

Latest Appointment31 May, 2017

 

Mr. López-Belmonte López has served as the Chairman of our Board of Directors for over 24 years. He holds a degree in business and economics from the Universidad Complutense de Madrid in 1969 and Insurance Actuary. He was first appointed as a director of the Company on July 27, 2007, when Rovi was admitted to trading on the stock market, and was re-elected at the shareholders’ general meeting in 2012 and 2017. He has been President of the Chamber of Commerce of Madrid from April 2016 until April 2018. Has has been President of Personal Healthcare Association (ANEFP) and Deputy Chairman of Farmaindustria (National Trade Association of the Spanish based pharmaceutical industry). He is a shareholder of Norbel Inversiones, S.L. (Rovi’s controlling shareholder), with a holding of 20%.

Other Boards of Directors on which he sits
+-
Company
Position
  1. Company: 
    NORBEL INVERSIONES, S.L.
    Position / Partner: 
    Chairman
  2. Company: 
    NORBEPA INVERSIONES, S.L.
    Position / Partner: 
    Chairman
  3. Company: 
    LOBEL Y LOSA DEVELOPMENT, S.L.
    Position / Partner: 
    Chairman
  4. Company: 
    INVERSIONES BORBOLLÓN, S.L.
    Position / Partner: 
    Chairman
  5. Company: 
    ALENTIA BIOTECH, S.L.
    Position / Partner: 
    Chairman
Shares held in company
+-

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr. Juan López-Belmonte Encina

Board member and Chief Executive Manager

PositionExecutive

First Appointment27 July, 2007

Latest Appointment31 May, 2017

 

Mr. López-Belmonte Encina is Chief Executive Officer and a member of our Board of Directors. He holds a degree in Economic and Business Economics from Universidad CEU San Pablo, Madrid, with an emphasis in auditing in 1993. He is a shareholder of Norbel Inversiones, S.L. (ROVI’s controlling shareholder), with a holding of 26.67%, and ROVI’s General Manager and CEO. He is currently the Deputy Chairman of the Board of Governors and Executive Board of Farmaindustria and he was Chairman of the R&D&I Committee of the CEOE from March 2015 until the end of 2018 (Spanish Confederation of Business Organizations). He began his professional career working in important international pharmaceutical companies in the United States and in the United Kingdom, in different pharmaceutical areas. He has been working for the Company since 1994, was appointed General Manager in 2001 and, since October 2007, he has been the Company’s Chief Executive Officer. He was first appointed as a director of the Company on July 27, 2007, when Rovi was admitted to trading on the stock market and was re-elected at the shareholders’ general meeting in 2012 and 2017.

Other Boards of Directors on which he sits
+-
Company
Position
  1. Company: 
    NORBEL INVERSIONES, S.L.
    Position / Partner: 
    Member
  2. Company: 
    NORBEPA INVERSIONES, S.L.
    Position / Partner: 
    Member
  3. Company: 
    ALENTIA BIOTECH, S.L.
    Position / Partner: 
    Member
Shares held in company
+-

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr. Iván López-Belmonte Encina

1st Vicepresicent

PositionExecutive

First Appointment27 July, 2007

Latest Appointment31 May, 2017

 

Mr. López-Belmonte Encina is our Head of Corporate Development and a member of our Board of Directors. He holds a degree in Business and Economic and from Universidad CEU San Pablo de Madrid, with an emphasis in auditing, in 1994. He is a shareholder of Norbel Inversiones, S.L. (ROVI’s controlling shareholder), with a holding of 26.67%, and First Deputy Chairman of the Board of Directors of ROVI. He began his professional career in Germany, working in pharmaceutical sector companies such as Amersham, engaged in nuclear medicine, and Hexal AG, specialized in generics. He has been working for the Company since 1995 and has been ROVI’s Corporate Development Manager since September 2007. He was first appointed as a director of the Company on 27 July, 2007, when ROVI was admitted to trading on the stock market, and was re-elected at the General Shareholders’ Meeting held on 31 May, 2017.

Other Boards of Directors on which he sits
+-
Company
Position
  1. Company: 
    NORBEL INVERSIONES, S .L.
    Position / Partner: 
    Director
  2. Company: 
    BERTEX PHARMA GMBH
    Position / Partner: 
    Joint and Several Administrator
  3. Company: 
    NORBEPA INVERSIONES, S.L.
    Position / Partner: 
    Director
  4. Company: 
    ENERVIT NUTRITION, S.L.
    Position / Partner: 
    Chairman and CEO
Shares held in company
+-

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr. Javier López-Belmonte Encina

2nd Vicepresident

PositionExecutive

First Appointment27 July, 2007

Latest Appointment31 May, 2017

 

Mr. López-Belmonte Encina our Chief Financial Officer and a member of our Board of Directors. He holds a degree in Business and Economics from Colegio Universitario de Estudios Financieros (CUNEF), Madrid, with an emphasis on finane in 1998. He holds a joint Executive MBA degree by Brown University and IE Madrid in 2017. He is a shareholder of Norbel Inversiones, S.L. (ROVI’s controlling shareholder), with a holding of 26.67%, and Second Deputy Chairman of the Board of Directors of ROVI. He is a member of Boards of Directors of CEIM (Madrid Business Confederation). He is a member of the Social Council of the Universidad Autónoma de Madrid on behalf of CEIM. Likewise, he is a member of the foundation´s board Universidad Autónoma de Madrid on behalf of Social Council of the Universidad Autónoma de Madrid. He began his professional career in the banking sector in 1998, working for Argentaria, S.A. in the United Kingdom as an analyst and, in the pharmaceutical sector, with Medeva Pharma, also in the United Kingdom. He joined ROVI in 2000 and has been Chief Financial Officer since 2001. He was first appointed as a director of the Company on 27 July, 2007, when ROVI was admitted to trading on the stock market, and was re-elected at the General Shareholders’ Meeting held on 13 June, 2012.

Other Boards of Directors on which he sits
+-
Company
Position
  1. Company: 
    NORBEL INVERSIONES, S.L.
    Position / Partner: 
    Member
  2. Company: 
    NORBEPA INVERSIONES, S.L.
    Position / Partner: 
    CEO and Secretary
  3. Company: 
    ALENTIA BIOTECH, S.L.
    Position / Partner: 
    Deputy Secretary
  4. Company: 
    ENERVIT NUTRITION, S.L.
    Position / Partner: 
    Member/Secretary
Shares held in company
+-

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr. Enrique Castellón Leal

Adviser and coordinator

PositionIndependent

First Appointment24 October, 2007

Latest Appointment31 May, 2017

 

Mr. Castellón Leal is an independent member of our Board of Directors. He holds a degree in Medicine and Surgery with a specialty in internal medicine from the Universidad Complutense de Madrid and a degree in Business and from the Universidad Autónoma de Madrid. Likewise, he holds Master’s degrees in Public Health and Health Policy and Management from the University of Harvard. He has been a physician with the Internal Medicine Service at Hospital Clínico San Carlos, Madrid, a Social Security Medical Inspector, General Manager of the Galician Health Service, Deputy Head of the Health Department of the Madrid Autonomous Region and Undersecretary at the Ministry of Health and Consumption. Likewise, he regularly advises several foundations engaged in health science research and carries on consulting activities with Castellón Abogados. He has worked as a consultant on health policy matters for the Inter-American Development Bank (World Bank Group) and is a founding shareholder and Chairman of the Board of Director of Cross Road Biotech SCR and of Cross Road Biotech Inversiones Biotecnológicas SA SGEIC. He currently provides consulting services to various organizations focused on health sciences research and provides consulting services to Castellón Abogados. He was appointed as independent member of our Board of Directors in 2007. He was re-elected at the shareholders’ general meeting in 2012 and 2017.

Other Boards of Directors on which he sits
+-
Company
Position
  1. Company: 
    CROSS ROAD BIOTECH, SCR
    Position / Partner: 
    Chairman of the Board
  2. Company: 
    OWL GENOMICS, S.L.
    Position / Partner: 
    Director
  3. Company: 
    BIOCROSS, S.L.
    Position / Partner: 
    Director
  4. Company: 
    CROSS ROAD BIOTECH INVERSIONES BIOTECNOLÓGICAS SGEIC, S.A.
    Position / Partner: 
    Chairman
  5. Company: 
    ATLAS MOLECULAR PHARMA, S.L.
    Position / Partner: 
    Director
  6. Company: 
    HEALTH IN CODE, S.L.
    Position / Partner: 
    Chairman
  7. Company: 
    VENTER PHARMA, S.L.
    Position / Partner: 
    Chairman
  8. Company: 
    ADDITUM BLOCKCHAIN, S.L.
    Position / Partner: 
    Deputy Chairman
Shares held in company
+-

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr. Marcos Peña Pinto

Board member

PositionIndependent

First Appointment7 May, 2019

Latest Appointment7 May, 2019

 

Mr. Marcos Peña Pinto holds a degree in Law from the Universidad Complutense de Madrid, having passed the examination for the Inspectorate of Technical Work and Social Security. From 1984 to 1989, Mr. Peña held the position of Employment Counsellor at the Spanish Embassy in Italy; later, from 1991 to 1996, he held the positions of General Health Secretary in the Ministry of Health and Consumer Affairs and General Employment and Labour Relations Secretary in the Ministry of Labour. From 2005 to 2006, he was an Expert Counsellor of the Economic and Social Council, acting as Chairman of this Council until April 2019. Furthermore, Mr. Peña Pinto has been Counsellor of the State Council (“Consejero Nato”), position which was linked to the chairmanship of the Economic and Social Council. As for other professional activities carried out by Mr. Marcos Peña, it is worth mentioning that he is specialized in collective bargaining, having held the position of Chairman of the Negotiation Commission in multiple collective agreements (e.g., Telefónica, RENFE, Repsol, Alcatel, Endesa, Astilleros, etc). Moreover, Mr. Peña is an arbitrator and mediator in different labour conflicts at a national level, as well as author of numerous publications and regular columnist in the written press.

Other Boards of Directors on which he sits
+-
Company
Position
Shares held in company
+-

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr. José Fernando de Almansa Moreno-Barreda

Board member

PositionIndependent

First Appointment9 June, 2015

Latest Appointment9 June, 2015

 

Mr. Almansa Moreno-Barreda holds a Law degree from the University of Deusto (Bilbao). He joined the Diplomatic Service on 2 December, 1974 and, from 1976 to 1992, held a variety of positions: Secretary of the Spanish Embassy in Brussels, Cultural Attaché at the Spanish Embassy in Mexico, Chief Director of the Coordination Section of the Subdirectorate-General for Eastern Europe, Director of Atlantic Affairs at the Directorate-General of Foreign Policy for Europe and Atlantic Affairs, Political Counsellor to the Permanent Representative of Spain on the North Atlantic Council in Brussels, Minister-Counsellor of the Spanish Embassy in the Soviet Union, Secretary General of the National Commission for the V Centenary of the Discovery of American and Subdirector General for Eastern Europe, reporting to the Directorate-General of Foreign Policy for Europe. From 1993 to 2002, he held the position of Head of the King’s Household, with the rank of Minister, having been appointed by HRH. King Juan Carlos I, and was likewise appointed Privy Counsellor to HRH King Juan Carlos I. From 9th of June 2015, he is director of ROVI.

Other Boards of Directors on which he sits
+-
Company
Position
  1. Company: 
    Telefónica Móviles México, S.A. de C.V.
    Position / Partner: 
    Director
Shares held in company
+-

% of voting rights

% Direct
% Indirect
% Total

0
0
0

Mr. Gabriel Núñez Fernández

Secretary non board member

Position

First Appointment

Latest Appointment

 

Other Boards of Directors on which he sits
+-
Company
Position
Shares held in company
+-

% of voting rights

% Direct
% Indirect
% Total


Mr. Ignacio Zarzalejos Toledano

Deputy Secretary non board member

Position

First Appointment

Latest Appointment

 

Other Boards of Directors on which he sits
+-
Company
Position
Shares held in company
+-

% of voting rights

% Direct
% Indirect
% Total